The Future of the Orthokeratology Market: Analysis and Forecast to 2030

Comments · 12 Views

Market Overview:
The Orthokeratology Market is estimated to be valued at US$ 37.6 million in 2023 and is expected to reach US$ (incorporate given market value for 2023) Bn/Mn by 2023, growing at a CAGR of 7.0% during the forecast period from 2023 to 2030. Orthokeratology, also known as Ortho-K, is a non-surgical corneal reshaping technique that uses specially designed contact lenses to temporarily reshape the cornea, leading to improved vision without the need for eyeglasses or daytime contact lenses. This procedure is gaining popularity among individuals who are seeking alternatives to laser refractive surgery and daily wear contact lenses. The application of Ortho-K lenses in the treatment of myopia, astigmatism, and presbyopia is expected to drive the market growth in the coming years.

Market Dynamics:
The Orthokeratology Market is driven by major factors such as increasing prevalence of myopia worldwide and the growing demand for non-surgical vision correction procedures. Additionally, the convenience and temporary nature of Ortho-K lenses, which allow patients to achieve improved vision during the day without the need for glasses or contact lenses, are further propelling market growth. Moreover, technological advancements in contact lens manufacturing, such as the use of advanced materials and designs, are expected to enhance the adoption of Ortho-K lenses. However, limited availability of trained practitioners and the high cost of Ortho-K lenses may hinder market growth to some extent.

Market key trends:
The key trend in the orthokeratology market is the growing popularity of myopia control. Myopia, or nearsightedness, is a common vision problem that has been increasing at an alarming rate, particularly among children. This has led to a rising demand for methods to slow down or halt the progression of myopia. Orthokeratology, also known as ortho-k, is a non-invasive treatment that uses gas-permeable contact lenses to reshape the cornea overnight, providing clear vision during the day without the need for glasses or contact lenses. This procedure has gained traction as an effective myopia control method, as it not only corrects refractive errors but also slows down the axial elongation of the eye, which is the main cause of myopia progression. With the increasing concern about the long-term implications of myopia and the desire to reduce the dependence on corrective eyewear, the demand for orthokeratology is expected to rise significantly in the coming years.

SWOT Analysis:
Strength: Orthokeratology offers a non-surgical and reversible method to correct refractive errors and slow down myopia progression, making it a popular choice among individuals seeking alternatives to glasses and contact lenses.
Weakness: The effectiveness of orthokeratology may vary among individuals, and the treatment requires strict adherence to wearing the lenses overnight and regular follow-up visits, which may be a challenge for some patients.
Opportunity: The growing prevalence of myopia worldwide presents a tremendous opportunity for the orthokeratology market, as more individuals seek effective methods to manage and control their myopia.
Threats: The availability of other myopia control methods, such as atropine eye drops and soft contact lenses, may pose a threat to the orthokeratology market. Additionally, regulatory hurdles and safety concerns associated with ortho-k may also impede market growth.

Key Takeaways:
The Global Orthokeratology Market Size is expected to witness high growth, exhibiting a CAGR of 7.0% over the forecast period (2023-2030). The increasing concern about myopia control and the desire for effective alternatives to glasses and contact lenses are the key drivers for market growth.

From a regional perspective, Asia Pacific is the fastest-growing and dominating region in the orthokeratology market. The high prevalence of myopia in countries like China and South Korea, coupled with the increasing adoption of ortho-k as a myopia control method, is driving market growth in this region.

Key players operating in the orthokeratology market include Autek China, Alpha Corporation, Bausch and Lomb Inc., Euclid Systems, E & E Optics, Essilor International S.A., GP Specialists, Paragon Vision Sciences, Procornea, and Taiwan Macro Vision Corporation. These key players are actively involved in research and development activities to enhance their product offerings and expand their market presence.

Read More- https://www.insightprobing.com/orthokeratology-market-insights-forecast-and-growth-analysis/  

disclaimer
Comments